Corrigenda: Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias(Journal of Thrombosis and Haemostasis 2012(S1538783622008327), (10.1111/j.1538-7836.2011.04583.x));Risk of obstetric and thromboembolic complications in family members of women with previous adverse obstetric outcomes carrying common inherited thombophilias

Journal of Thrombosis and Haemostasis

Volumn 10, Issue 2, 2012, Pages 223-228

  Villani, M ^a   Tiscia, G L ^a   Margaglione, M ^b   Colaizzo, D ^a   Fischetti, L ^a   Vergura, P ^a   Grandone, E ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

Author keywords

Inherited thrombophilia; Pregnancy complications; Venous thromboembolism

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; PROTHROMBIN A;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILY; FEMALE; GENE MUTATION; HETEROZYGOSITY; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PREGNANCY OUTCOME; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE; THROMBOPHILIA; VENOUS THROMBOEMBOLISM;

EID: 84856514685     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2012.04783_1.x     Document Type: Erratum

References (22)

1. Rotmensch S, Liberati M, Mittelmann M, Ben-Rafael Z. Activated protein C resistance and adverse pregnancy outcome. Am J Obstet Gynecol 1997; 177: 170-3.
2. Rodger MA, Betancourt MT, Clark P, Lindqvist PG, Dizon-Townson D, Said J, Seligsohn U, Carrier M, Salomon O, Greer IA. The association of factor V leiden and prothrombin gene mutation and placenta-mediated pregnancy complications: a systematic review and meta-analysis of prospective cohort studies. PloS Med 2010; 7: e1000292.
3. Grandone E, Margaglione M, Colaizzo D, Cappucci G, Sciannamé N, Montanaro S, Paladini D, Martinelli P, Di Minno G. Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria. Thromb Haemost 1999; 81: 349-52.
4. Grandone E, Tomaiuolo M, Colaizzo D, Ames PR, Margaglione M. Role of thrombophilia in adverse obstetric outcomes and their prevention using antithrombotic therapy. Semin Thromb Hemost 2009; 35: 630-43.
5. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003; 16: 153-68.
6. Jackson E, Curtis KM, Gaffield ME. Risk of venous thromboembolism during the postpartum period. a systematic review. Obstet Gynecol 2011; 117: 691-703.
7. James AH. Venous thromboembolism in pregnancy. Arterioscler Thromb Vasc Biol 2009; 29: 326-31.
8. Martinelli I, Bucciarelli P, Margaglione M, De Stefano V, Castaman G, Mannucci PM. The risk of venous thromboembolism in family members with mutations in the genes of factor V or prothrombin or both. Br J Haematol 2000; 111: 1223-9.
9. Bank I, Libourel EJ, Middeldorp S, van Pampus EC, Koopman MM, Hamulyák K, Prins MH, van der Meer J, Buller HR. Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study. Arch Intern Med 2004; 164: 1932-7.
10. Tormene D, De Stefano V, Grandone E, Za T, Perlati M, Rossi E, Margaglione M, Simioni P. The G20210A prothrombin variant and the risk of venous thromboembolism or fetal loss in pregnant women: a family study. J Thromb Haemost 2007; 5: 2193-6.
11. Segal JB, Brotman DJ, Necochea AJ, Emadi A, Samal L, Wilson LM, Crim MT, Bass EB. Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review. JAMA 2009; 301: 2472-85.
12. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Recommendations from the EGAPP Working Group: routine testing for Factor V Leiden (R506Q) and prothrombin (20210G>A) mutations in adults with a history of idiopathic venous thromboembolism and their adult family members. Genet Med 2011; 13: 67-76.
13. Tiscia G, Colaizzo D, Chinni E, Pisanelli D, Sciannamè N, Favuzzi G, Margaglione M, Grandone E. Haplotype M2 in the annexin A5 (ANXA5) gene and the occurrence of obstetric complications. Thromb Haemost 2009; 102: 309-13.
14. The Practice Committee of the American Society for Reproductive Medicine, Definitions of infertility and recurrent pregnancy loss. Fertil Steril 2008; 89: 1603.
15. Lussana F, Dentali F, Abbate R, d'Aloja E, D'Angelo A, De Stefano V, Faioni EM, Grandone E, Legnani C, Martinelli I, Simioni P, Tormene D; Italian Society for Haemostasis and Thrombosis. Screening for thrombophilia and antithrombotic prophylaxis in pregnancy: Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET). Thromb Res 2009; 124: e19-25.
16. American College of Obstetricians ad Gynecologists Committee on Obstetric Practice. ACOG practice bulletin, number 33, January 2002. Diagnosis and management of preeclampsia and eclampsia. American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet 2002; 77: 67-75.
17. Paladini D, Rustico M, Viora E, Giani U, Bruzzese D, Campogrande M, Martinelli P. Fetal size charts for the Italian population. Normative curves of head, abdomen and long bones. Prenat Diagn 2005; 25: 456-64.
18. Pabinger I, Grafenhofer H, Kaider A, Ilic A, Eichinger S, Quehenberger P, Husslein P, Mannhalter C, Lechner K. Preeclampsia and fetal loss in women with a history of venous thromboembolism. Arterioscler Thromb Vasc Biol 2001; 21: 874-9.
19. Grandone E, Colaizzo D, Brancaccio V, Ciampa A, Di Minno G, Margaglione M. Impact of prothrombotic mutations and family history on the occurrence of intra-uterine fetal deaths. Haematologica 2002; 87: 1118-9.
20. Rossi E, Ciminello A, Za T, Betti S, Leone G, De Stefano V. In families with inherited thrombophilia the risk of venous thromboembolism is dependent on the clinical phenotype of the proband. Thromb Haemost 2011; 106: 646-54.
21. Z∂ller B, Li X, Sundquist J, Sundquist K. Parental history and venous thromboembolism: a nationwide study of age-specific and sex-specific familial risks in Sweden. J Thromb Haemost 2011; 9: 64-70.
22. Moll S. Who should be tested for thrombophilia? Genet Med 2011; 13: 19-20.